Orgenesis Inc is a biotechnology company that specializes in the development and commercialization of cell and gene therapies. The company focuses on innovative treatment solutions aimed at addressing various diseases, including diabetes and liver disorders. Orgenesis is particularly known for its proprietary platform that enables the transformation of cells into therapeutically beneficial entities, potentially leading to groundbreaking advancements in regenerative medicine. Additionally, the company is involved in creating a global network of cell therapy facilities to streamline and optimize the manufacturing process, ensuring that advanced therapies are accessible to patients in need. Read More
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.
